Biogen (BIIB) Net Income - Minority (2009 - 2023)

Biogen (BIIB) posted quarterly Net Income - Minority of $4.1 million for Q3 2023, down 52.87% year-over-year from $8.7 million in Q3 2022, and down 35.94% on a QoQ basis from $6.4 million in Q2 2023.

Biogen (BIIB) Net Income - Minority (2009 - 2023) Analysis & Trends

Biogen (BIIB) has reported Net Income - Minority for 15 consecutive years, with $4.1 million the latest figure, recorded in Q3 2023.

  • In Q3 2023, Net Income - Minority fell 52.87% year-over-year to $4.1 million; the TTM figure through Sep 2023 stood at $4.1 million (down 52.87% YoY), while the FY2022 annual figure was $9.5 million, up 114.96% from the prior year.
  • Net Income - Minority came in at $4.1 million for Q3 2023 at Biogen, down from $6.4 million in the prior quarter.
  • The five-year high for Net Income - Minority was $21.6 million in Q1 2022, with the low at -$462.9 million in Q2 2021.
  • Average Net Income - Minority over 5 years is -$42.8 million, with a median of $8.7 million recorded in 2022.
  • Across the five-year window, Net Income - Minority jumped 375.61% in 2020 and tumbled 3327.14% in 2021, its largest moves.
  • Year by year, Net Income - Minority stood at $4.1 million in 2019, then soared by 246.34% to $14.2 million in 2020, then plunged by 547.18% to -$63.5 million in 2021, then soared by 114.96% to $9.5 million in 2022, then slumped by 56.84% to $4.1 million in 2023.
  • According to Business Quant data, Net Income - Minority over the past three periods registered $4.1 million, $6.4 million, and $9.6 million for Q3 2023, Q2 2023, and Q1 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income - Minority (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2023 4.10 Mn
Jun 30, 2023 6.40 Mn
Mar 31, 2023 9.60 Mn
Dec 31, 2022 9.50 Mn
Sep 30, 2022 8.70 Mn
Jun 30, 2022 9.10 Mn
Mar 31, 2022 21.60 Mn
Dec 31, 2021 -63.50 Mn
Sep 30, 2021 -451.80 Mn
Jun 30, 2021 -462.90 Mn
Mar 31, 2021 19.00 Mn
Dec 31, 2020 14.20 Mn
Sep 30, 2020 14.00 Mn
Jun 30, 2020 19.50 Mn
Mar 31, 2020 10.00 Mn
Dec 31, 2019 4.10 Mn
Sep 30, 2019 4.10 Mn
Jun 30, 2019 4.10 Mn
Mar 31, 2019 7.90 Mn
Dec 31, 2018 8.00 Mn